Intensive lifestyle intervention, cardiac biomarkers, and cardiovascular outcomes in diabetes: LookAHEAD cardiac biomarker ancillary study
Patel KV, Chunawala Z, Verma S, et al.
JACC. Pub. online 15 Nov 2024.
Leggi
Increased cardiovascular risk in people with LADA in comparison to type 1 diabetes and type 2 diabetes: Findings from the DPV registry in Germany and Austria
Golomb RC, Tittel SR, Welters A, et al.
Diabetes Obes Metab. Pub. online 11 Nov 2024.
Leggi
Enrollment of females in randomized trials for glucagon-like peptide 1 receptor agonists: a systematic review
Rivera FB, Ybañez MJ, Magalong JV, et al.
JACC Adv. 2024;3(12):101386.
Leggi
NT proBNP improves prediction of cardiorenal complications in type 2 diabetes: the Hong Kong Diabetes Biobank
Ma RCW, Tam CHT, Hou Y, et al.
Diabetologia. Pub. online 7 Nov 2024.
Leggi
Interventions in women with type 2 diabetes mellitus in the pre-pregnancy, pregnancy and postpartum periods to optimise care and health outcomes: a systematic review
Gunabalasingam S, Kyrka A, Hopkins L, et al.
Diabet Med. Pub. online 11 Nov 2024.
Leggi
Association of time in range with cognitive impairment in middle-aged type 2 diabetic patients
Liu Y, Liu Y, Qiu H, et al.
BMC Endocr Disord. Pub. online 8 Nov 2024.
Leggi
Increased risk of major adverse cardiovascular events in patients with deep and infected diabetes-related foot ulcers
Lan NSR, Hiew J, Ferreira I, et al.
Diabetologia. Pub. online 7 Nov 2024.
Leggi
Time in tight range: a key metric for optimal glucose control in the era of advanced diabetes technologies and therapeutics
Zhang Z, Wang Y, Lu J, Zhou J
Diabetes Obes Metab. Pub. online 11 Nov 2024.
Leggi
Relationship between timing of coffee and tea consumption with mortality (total, cardiovascular disease and diabetes) in people with diabetes: the U.S. National Health and Nutrition Examination Survey, 2003–2014
Yang R, Lei Q, Liu Z, et al.
BMC Med. Pub. online 11 Nov 2024.
Leggi
